Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes
This study is currently recruiting participants.
Verified November 2011 by Ageless Regenerative Institute
Study NCT01453751   Information provided by Ageless Regenerative Institute

First Received on October 3, 2011.   Last Updated on November 1, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus Type II
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Sponsors listed in this trial
Ageless Regenerative Institute
Instituto de Medicina Regenerativa, S.A. de C.V.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services